Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22724029 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Efficacy/Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) and SSG/PM Combination to Treat V Leishmaniasis
Condition: Visceral Leishmaniasis
Interventions: Drug: Sodium Stibogluconate;   Drug: Paromomycin sulphate;   Drug: SSG and Paromomycin sulphate

Indicates status has not been verified in more than two years